Molly Harper

Molly Harper is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a board member for Catalyst Pharmaceuticals, Inc. and PreciseDx, and as Chief Strategy & Business Officer at Synlogic, Inc., Molly has held significant leadership roles at various organizations, including Executive Vice President of Operations at Relmada Therapeutics, Inc. and multiple positions at Akcea Therapeutics, including SVP & GM for Cardiometabolic and Transthyretin Amyloidosis Franchises. Previous roles include Head & General Manager for Genzyme's US Endocrinology division and various marketing and planning positions at Merck, Johnson & Johnson, UBS, and The Wilkerson Group/IBM. Molly holds an MBA in Healthcare Management from The Wharton School and a BA in English, cum laude, from Cornell University.